Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group A : Injection Triamcinolone acetonide (40mg/ml) + 2 % lignocaine with epinephrine: Group A patients :
Patients will be clinically examined and a diagnosis of Irritable larynx synd
Sponsors
All India Institute of Medical Sciences, Raebareli
Eligibility
Inclusion criteria
Inclusion criteria: Patients with symptoms of Irritable larynx syndrome: 1. Chronic neurogenic cough 2. Chronic throat clearing 3. Globus sensation (lump in the throat) 4. Episodic laryngospasm 5. Dysphonia 6. Throat pain (muscle tension) 7. Odynophagia
Exclusion criteria
Exclusion criteria: 1.Anatomical abnormality and disorders of larynx (laryngeal or oropharyngeal malignancy, infections like tuberculosis, fungal) 2.Functional disorders of the larynx (vocal cord palsy). 3.Chronic alcoholics or smokers. 4.Stylalgia 5.Pregnant ladies 6.Patients with known psychiatric disorders 7.Patients with known bleeding disorders 8.Patients on any concurrent neuromodulator therapy 9.Post operative patients of voice disorders (post micro laryngeal surgery patients) 10.Patients not providing informed consent. 11.Patient allergic to lignocaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reflux symptom index (RSI) Cough severity index (CSI)Timepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptomatic relief for the patientTimepoint: 15 days 30 days 45 days | — |
Countries
India
Contacts
Public ContactAnnanya Soni
All India Institute of Medical Sciences, Raebareli
Outcome results
None listed